Prener Anne

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Prener Anne
CIK #0001797917
EDGAR Form CIK 2011 - 2026
3 [0001797917]
4 [0001797917]
Form 3/4/5 Subject 2011 - 2026
Prener Anne
Keros Therapeutics Inc
Damora Therapeutics Inc
Rubius Therapeutics Inc
Kaleido Biosciences Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2025-06-18 Grant 720 $0.00
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2024-06-20 Grant 18,000 $0.00
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2023-06-14 Grant 18,000 $0.00
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2022-06-14 Grant 18,000 $0.00
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
2022-05-12 Grant 25,000 $0.00
Kaleido Biosciences Inc KLDO
Stock Option (Right to Buy) · derivative
2021-06-30 Grant 15,000 $0.00
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2021-05-26 Grant 18,000 $0.00
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
2021-05-12 Grant 25,000 $0.00
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2021-01-08 Grant 18,000 $0.00
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2021-01-08 Grant 6,000 $0.00
Kaleido Biosciences Inc KLDO
Stock Option (Right to Buy) · derivative
2020-06-30 Grant 15,000 $0.00
Kaleido Biosciences Inc KLDO
Stock Option (Right to Buy) · derivative
2020-04-01 Grant 30,000 $0.00
Rubius Therapeutics Inc RUBY
Stock Option (Right to Buy) · derivative
2019-12-31 Grant 50,000 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com